Description
Bilypsa 4mg Tablet contains Saroglitazar, a PPAR agonist used in the management of diabetic dyslipidemia and type 2 diabetes. This medication helps improve glycemic control and lipid profile in patients with diabetes. Bilypsa 4mg Tablet is indicated for patients requiring management of both glycemic and lipid parameters. The product is available in tablet form for convenient oral administration. Use the product according to the instructions provided on the packaging or as advised by a healthcare professional. Please read the product label carefully and follow all recommended precautions and warnings before using this medicine. Important Note: This information is for general product purposes only and is not intended as medical advice. Always consult a healthcare professional before use.
Reviews
There are no reviews yet.